Medtronic received information via literature regarding the outcomes following the ross procedure in children and young adults.All data were retrospectively collected from a single center between may 2003 and may 2018.The study population included 18 patients (predominantly female; median age 15 years), one was implanted with a medtronic contegra valved conduit and one was implanted with a medtronic freestyle bioprosthetic valve (no serial numbers provided).Among all patients, 3 early post-operative deaths occurred due to: cardiac arrest (1 case) and multi-organ failure (2 cases).Multiple manufacturers were noted in the literature; based on the available information, medtronic product was not directly associated with the deaths.Among all patients, adverse events included: conduit stenosis requiring balloon angioplasty (1 case at 3 years post implant and 1 case at 8 years post implant), autograft/aortic root dilatation, elevated left ventricular outflow tract gradients, mild-moderate aortic and pulmonary insufficiency.Based on the available information, medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|